Torsdag 22 Oktober | 10:13:35 Europe / Stockholm
Est. tid*
2027-02-05 08:00 Bokslutskommuniké 2026
2026-10-30 N/A Extra Bolagsstämma 2026
2026-10-22 08:00 Kvartalsrapport 2026-Q3
2026-07-17 - Kvartalsrapport 2026-Q2
2026-06-02 - X-dag ordinarie utdelning HUM 1.35 SEK
2026-06-01 - Årsstämma
2026-04-24 - Kvartalsrapport 2026-Q1
2026-02-06 - Bokslutskommuniké 2025
2025-10-24 - Kvartalsrapport 2025-Q3
2025-07-18 - Kvartalsrapport 2025-Q2
2025-05-07 - X-dag ordinarie utdelning HUM 1.00 SEK
2025-05-06 - Årsstämma
2025-04-24 - Kvartalsrapport 2025-Q1
2025-02-06 - Bokslutskommuniké 2024
2024-10-23 - Kvartalsrapport 2024-Q3
2024-07-19 - Kvartalsrapport 2024-Q2
2024-05-08 - X-dag ordinarie utdelning HUM 0.00 SEK
2024-05-07 - Årsstämma
2024-04-25 - Kvartalsrapport 2024-Q1
2024-02-08 - Bokslutskommuniké 2023
2023-10-27 - Kvartalsrapport 2023-Q3
2023-07-21 - Kvartalsrapport 2023-Q2
2023-05-10 - X-dag ordinarie utdelning HUM 0.00 SEK
2023-05-09 - Årsstämma
2023-05-04 - Kvartalsrapport 2023-Q1
2023-02-09 - Bokslutskommuniké 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-08-18 - Kvartalsrapport 2022-Q2
2022-05-11 - X-dag ordinarie utdelning HUM 0.00 SEK
2022-05-10 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-10 - Bokslutskommuniké 2021
2021-11-11 - Kvartalsrapport 2021-Q3
2021-08-20 - Kvartalsrapport 2021-Q2
2021-05-12 - X-dag ordinarie utdelning HUM 0.00 SEK
2021-05-11 - Årsstämma
2021-05-06 - Kvartalsrapport 2021-Q1
2021-02-11 - Bokslutskommuniké 2020
2020-11-06 - Kvartalsrapport 2020-Q3
2020-08-20 - Kvartalsrapport 2020-Q2
2020-05-08 - X-dag ordinarie utdelning HUM 0.00 SEK
2020-05-07 - Årsstämma
2020-05-07 - Kvartalsrapport 2020-Q1
2020-02-13 - Bokslutskommuniké 2019
2019-05-10 - X-dag ordinarie utdelning HUM 0.70 SEK
2019-05-09 - Årsstämma
2019-02-14 - Bokslutskommuniké 2018
2018-11-16 - Kvartalsrapport 2018-Q3
2018-08-17 - Kvartalsrapport 2018-Q2
2018-05-17 - X-dag ordinarie utdelning HUM 0.60 SEK
2018-05-16 - Årsstämma
2018-05-16 - Kvartalsrapport 2018-Q1
2018-02-21 - Bokslutskommuniké 2017
2017-11-16 - Kvartalsrapport 2017-Q3
2017-08-18 - Kvartalsrapport 2017-Q2
2017-05-19 - X-dag ordinarie utdelning HUM 0.50 SEK
2017-05-18 - Årsstämma
2017-05-18 - Kvartalsrapport 2017-Q1
2017-02-23 - Bokslutskommuniké 2016
2016-11-18 - Kvartalsrapport 2016-Q3
2016-08-19 - Kvartalsrapport 2016-Q2
2016-05-19 - Kvartalsrapport 2016-Q1
LandSverige
ListaMid Cap Stockholm
SektorHälsovård
IndustriVård & Omsorg
Humana är ett svenskt bolag med verksamhet inom vård och omsorg. Inom organisationen riktas huvudfokus mot individ- och familjeomsorg, personlig assistans och äldreomsorg. Bolaget erbjuder även korttidsboenden samt särskilt anpassade boenden. Tjänster som erbjuds innefattar huvudsakligen personligt stöd samt psykiatriska behandlingar. Störst närvaro återfinns inom den nordiska marknaden. Bolaget grundades 1982 och har huvudkontor i Stockholm.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Humana reports third quarter and nine-month period 2026 results

2026-10-22 08:00:00

Highest profit in a quarter and improved margin

President and CEO Nathalie Boulas Nilsson comments:

The third quarter of 2026 continued in a positive direction, with our highest adjusted operating profit ever and an improved adjusted operating margin. The improvement is primarily being driven by Sweden through price increases and efficiencies within
Individual & Family. Demand within Nordic care continues to increase and we are meeting this demand by signing contracts for future care sites and continuing to expand our pipeline for growth, while our targeted efforts to promote organic growth are starting to generate results.

Summary of the third quarter

  • ·Net revenue was SEK 2,592 million (2,489), an increase of 4 percent.
  • Organic growth was 0.3 percent (-1.2).
  • Operating profit was SEK 213m (206).
  • Adjusted operating profit rose by 6 percent, totalling SEK 221m (208).
  • Profit for the period amounted to SEK 123m (120).
  • Earnings per share for the period amounted to SEK 2.58 (2.40).
  • Cash flow for the period amounted to SEK -46m (-346).
  • Free cash flow amounted to SEK 12m (-17). 

Summary of the nine-month period

  • ·Net revenue was SEK 7,649m (7,528).
  • Organic growth was -0.2 percent (-1.6).
  • Operating profit was SEK 356m (424), including the net effects of reclaims of SEK -18m and costs linked to IVO's revocation of permit of SEK -12m. The comparative period was positively impacted by the divestment of elderly care operations in Finland, which generated SEK 35m.
  • Adjusted operating profit amounted to SEK 410m (395).
  • Profit for the period amounted to SEK 152m (212).
  • Earnings per share for the period amounted to SEK 3.19 (4.18).
  • Cash flow for the period amounted to SEK -92m (-263).
  • Free cash flow amounted to SEK 183m (41).

 
Highlights

  • Adjusted operating profit increased by 6 percent
  • Improved adjusted operating margin
  • Positive organic growth
  • Stronger financial position, with a leverage ratio of 2.4x, well below the financial target
  • The growth pipeline expanded to a yearly revenue of SEK 615m


Significant events in the third quarter 2026 and after the reporting period

· In August, the Court of Appeal announced that they were granting leave to appeal regarding Humana Assistans AB’s appeal against the District Court’s ruling to reject the claim against the State. The leave to appeal means that the matter will be heard in the Court of Appeal.
· In October, it was announced that Humana had appointed Jenny Karlsson as acting business area manager for Personal Assistance in Sweden.
· In October, Ambea AB (publ.) declared that its public takeover offer to the shareholders of Humana was unconditional.
· In October, it was announced that Humana was applying for delisting and called an extraordinary general meeting. The last day of trading on Nasdaq Stockholm will be 27 October 2026.
· In October, The Group’s bank loans in SEK, NOK and EUR were repaid in their entirety by Ambea after the end of the reporting period. These bank loans have been replaced by intragroup financing from Ambea.
 

For more information, please contact:
Christoffer Herou
CFO
+46 72 582 86 16, christoffer.herou@humana.se

Ewelina Pettersson 
Head of Investor Relations
+46 73 074 79 12, ewelina.pettersson@humana.se